Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura

Samankaltaisia teoksia

• Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.
  Tekijä: Contessa E Edgar, et al.
  Julkaistu: (2015-01-01)
• Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura
  Tekijä: Edgar, Contessa E., et al.
  Julkaistu: (2015)
• BLOOD GROUP O AND BLACK RACE ARE INDEPENDENT RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH SEVERE ADAMTS13 DEFICIENCY
  Tekijä: Terrell, Deirdra R., et al.
  Julkaistu: (2011)
• Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura
  Tekijä: Little, Dustin J., et al.
  Julkaistu: (2017)
• Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015
  Tekijä: Page, Evaren E., et al.
  Julkaistu: (2017)